Axial Spondyloarthritis/Ankylosing Spondylitis Studies
The Division of Rheumatology strives to understand more about Spondyloarthritis through research. Please see the list below, which summarizes the studies available to individuals interested in advancing our understanding and treatment of rheumatic disease.
| Study Name/IRB#/PI | Brief Description | Basic Eligibility Criteria | Contact |
Program for individuals 17-0977 Liron Caplan, MD | Long-term research study of individuals at risk of spondyloarthritis (SpA). This study does not include a placebo group. | 1) Parent, child, or sibling (by blood) of someone with spondyloarthritis 2) Individuals with SpA or SpA associated conditions such as inflammatory bowel disease, psoriasis, or uveitis) | 303-724-3539 Andrew.stahly@cuanschutz.edu or click here to give your information to the study team. |
Interdisciplinary Joint Biology Program for Rheumatic and Orthopedic Diseases 20-1908 Larry Moreland, MD | The goal of the University of Colorado Interdisciplinary Joint Biology Program is to employ cutting edge science and technology to advance research of inflammatory, degenerative and musculoskeletal joint diseases | Individuals with RA, SpA, PsA, AS, OA or any other form of inflammatory arthritis with active disease in their elbow, wrist, hand joints, knee, ankle or shoulder and are willing to undergo a synovial biopsy at that site or individuals who are having an orthopedic surgery and are willing to donate their tissues that would normally be discarded | 303-724-7541 Jennifer.Seifert@cuanschutz.edu
|
|
|
Please note that study status changes frequently and therefore, a listed study may not be actively enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed due to its length. A visit to determine an individual’s eligibility may be required. A placebo is an inactive substance or treatment that looks the same as, and is given the same way as, an active drug or treatment being tested. The effects of the active drug or treatment are compared to the effects of the placebo.